Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2006-09-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM060475MPMID 17034142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Situ Neutralization in Boc-chemistry Solid Phase Peptide Synthesis

  2007cited by this paper
• Synthesis of the C‐terminal region of opioid receptor like 1 in an SDS micelle by the native chemical ligation: effect of thiol additive and SDS concentration on ligation efficiency

  2005cited by this paper
• Prospects for a group A streptococcal vaccine.

  2005cited by this paper
• Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.

  2005cited by this paper
• Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides.

  2005cited by this paper
• Vaccine development for group A streptococcus infections and associated disease.

  2004cited by this paper
• Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage.

  2004cited by this paper
• Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct.

  2004cited by this paper
• Total chemical synthesis of crambin.

  2004cited by this paper
• Potential of Lipid Core Peptide Technology as a Novel Self-Adjuvanting Vaccine Delivery System for Multiple Different Synthetic Peptide Immunogens

  2003cited by this paper
• Development of lipid-core-peptide (LCP) based vaccines for the prevention of group A streptococcal (GAS) infection

  2003cited by this paper
• Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes.

  2002cited by this paper
• A Lipid Core Peptide Construct Containing a Conserved Region Determinant of the Group A Streptococcal M Protein Elicits Heterologous Opsonic Antibodies

  2002cited by this paper
• The metal binding properties of the CCCH motif of the 50S ribosomal protein L36 from Thermus thermophilus.

  2001cited by this paper
• A lipophilic adjuvant carrier system for antigenic peptides

  2001cited by this paper
• Synthesis of a molt-inhibiting hormone of the American crayfish, Procambarus clarkii, and determination of the location of its disulfide linkages.

  2000cited by this paper
• New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population

  2000cited by this paper
• Group A streptococcal vaccines.

  1999cited by this paper
• Protein synthesis by native chemical ligation: expanded scope by using straightforward methodology.

  1999cited by this paper
• Direct preparation of peptide thioesters using an Fmoc solid-phase method

  1998cited by this paper
• Some peculiarities of synthesis of cysteine-containing peptides

  1998cited by this paper
• Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus.

  1997cited by this paper
• Proteinotopic feature maps

  1994cited by this paper
• Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci.

  1994cited by this paper
• Evaluation of secondary structure of proteins from UV circular dichroism spectra using an unsupervised learning neural network.

  1993cited by this paper
• A combined adjuvant and carrier system for enhancing synthetic peptides immunogenicity utilising lipidic amino acids

  1993cited by this paper
• Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies.

  1992cited by this paper
• Lipidic peptides, I. Synthesis, resolution and structural elucidation of lipidic amino acids and their homo- and hetero-oligomers

  1990cited by this paper
• Silver trifluoromethanesulphonate as an S-deprotecting reagent for the synthesis of cystine peptides

  1989cited by this paper
• Streptococcal M protein: molecular design and biological behavior

  1989cited by this paper
• Protective and autoimmune epitopes of streptococcal M proteins.

  1988cited by this paper
• Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction.

  1981cited by this paper
• Current knowledge of type-specific M antigens of group A streptococci.

  1962cited by this paper

• Self-Assembling Peptides for Vaccine Adjuvant Discovery

  2024cites this paper
• Lipopeptides for Vaccine Development

  2021cites this paper
• Built-in adjuvants for use in vaccines.

  2021cites this paper
• Opsonic Activity of Conservative Versus Variable Regions of the Group A Streptococcus M Protein

  2020cites this paper
• Application of built-in adjuvants for epitope-based vaccines

  2019cites this paper
• Rabies Virus 31D Peptide‐[P(VP‐co‐AA)] Conjugates: Synthesis, Characterization and Cytotoxicity Evaluation

  2019cites this paper
• Interleukin-13 peptide vaccine induces protective humoral immunity in murine asthma models

  2017cites this paper
• Synthesis of Multicomponent Peptide-Based Vaccine Candidates against Group A Streptococcus

  2017cites this paper
• Nanomaterials Based on Lipids for Vaccine Development

  2017cites this paper
• Evaluation of Lipopeptides as Toll-like Receptor 2 Ligands.

  2017cites this paper
• Double conjugation strategy to incorporate lipid adjuvants into multiantigenic vaccines

  2016cites this paper
• Nanoparticle-Based Peptide Vaccines

  2016cites this paper
• Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity.

  2014cites this paper
• Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group a streptococcal vaccines.

  2014cites this paper
• Modern Subunit Vaccines: Development, Components, and Research Opportunities

  2013cites this paper
• Lipo-Peptides/Saccharides for Peptide Vaccine Delivery

  2013cites this paper
• Immunostimulation by Synthetic Lipopeptide-Based Vaccine Candidates: Structure-Activity Relationships

  2013cites this paper
• Host-Pathogen Interactions in Streptococcal Diseases

  2013cites this paper
• Group a streptococcal vaccine candidates: potential for the development of a human vaccine.

  2013cites this paper
• An efficient, chemically-defined semisynthetic lipid-adjuvanted nanoparticulate vaccine development system.

  2013cites this paper
• Peptide-Based Subunit Vaccine against Hookworm Infection

  2012cites this paper
• Peptides as therapeutics with enhanced bioactivity.

  2012cites this paper
• Innovation in Vaccinology

  2012cites this paper
• TLR Agonists as Vaccine Adjuvants

  2012cites this paper
• Characterisation of anchorless cell-surface proteins: novel candidates for a safe and universal group a streptococcal vaccine

  2011cites this paper
• Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles

  2011cites this paper
• Modern lipid‐, carbohydrate‐, and peptide‐based delivery systems for peptide, vaccine, and gene products

  2011cites this paper
• Lipid-core-peptide system for self-adjuvanting synthetic vaccine delivery.

  2011cites this paper
• Development of highly pure α-helical lipoglycopeptides as self-adjuvanting vaccines

  2009cites this paper
• Vaccine delivery: synthesis and investigation of a highly pure, multi-epitopic lipopeptide vaccine candidate.

  2009cites this paper
• Design and Synthesis of Lipopeptide–Carbohydrate Assembled Multivalent Vaccine Candidates Using Native Chemical Ligation

  2009cites this paper
• Lipid Core Peptide System for Gene, Drug, and Vaccine Delivery

  2009cites this paper
• A novel synthetic adjuvant enhances dendritic cell function

  2009cites this paper
• Synthesis and in vivo studies of carbohydrate-based vaccines against group A streptococcus.

  2008cites this paper
• Self-adjuvanting lipopeptide vaccines.

  2008cites this paper
• Investigation toward multi-epitope vaccine candidates using native chemical ligation.

  2008cites this paper
• Recent Advances in Design and Synthesis of Self-Adjuvanting Lipopeptide Vaccines

  2008cites this paper
• Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates.

  2008cites this paper
• A technique for the synthesis of highly-pure, mono-epitopic, multi-valent lipid core peptide vaccines

  2007cites this paper
• Towards the development of a broadly protective group a streptococcal vaccine based on the Lipid-Core Peptide system.

  2007cites this paper